XML 25 R12.htm IDEA: XBRL DOCUMENT v3.8.0.1

Accrued Expenses

12 Months Ended

Dec. 31, 2017

Payables and Accruals [Abstract]

Accrued Expenses

Accrued Expenses

Accrued expenses and other current liabilities consisted of the following:

	As of
	December 31, 2017				December 31, 2016
Bonus	$	2,538,340			$	2,357,194
Deferred revenue-R&D for TPOXX® intravenous formulation	1,255,318				—
Professional fees	381,980				481,641
Vacation	328,588				262,664
Other	977,353				1,483,253
Accrued expenses and other current liabilities	$	5,481,579			$	4,584,752

X

- Definition

The entire disclosure for accrued liabilities and other current liabilities at the end of the reporting period.

+ References

No definition available.

+ Details

Name:	siga_AccruedExpensesAndOtherCurrentLiabilitiesTextBlock
Namespace Prefix:	siga_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration